Zobrazeno 1 - 6
of 6
pro vyhledávání: '"Anthony Victor D'Amico"'
Autor:
Edward M, Schaeffer, Sandy, Srinivas, Nabil, Adra, Yi, An, Daniel, Barocas, Rhonda, Bitting, Alan, Bryce, Brian, Chapin, Heather H, Cheng, Anthony Victor, D'Amico, Neil, Desai, Tanya, Dorff, James A, Eastham, Thomas A, Farrington, Xin, Gao, Shilpa, Gupta, Thomas, Guzzo, Joseph E, Ippolito, Michael R, Kuettel, Joshua M, Lang, Tamara, Lotan, Rana R, McKay, Todd, Morgan, George, Netto, Julio M, Pow-Sang, Robert, Reiter, Mack, Roach, Tyler, Robin, Stan, Rosenfeld, Ahmad, Shabsigh, Daniel, Spratt, Benjamin A, Teply, Jonathan, Tward, Richard, Valicenti, Jessica Karen, Wong, Ryan A, Berardi, Dorothy A, Shead, Deborah A, Freedman-Cass
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 20(12)
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, recurrent, and metastatic disease. The NCCN Prostate Cancer Panel meets annually to
Autor:
Edward, Schaeffer, Sandy, Srinivas, Emmanuel S, Antonarakis, Andrew J, Armstrong, Justin E, Bekelman, Heather, Cheng, Anthony Victor, D'Amico, Brian J, Davis, Neil, Desai, Tanya, Dorff, James A, Eastham, Thomas A, Farrington, Xin, Gao, Eric Mark, Horwitz, Joseph E, Ippolito, Michael R, Kuettel, Joshua M, Lang, Rana, McKay, Jesse, McKenney, George, Netto, David F, Penson, Julio M, Pow-Sang, Robert, Reiter, Sylvia, Richey, Mack, Roach Iii, Stan, Rosenfeld, Ahmad, Shabsigh, Daniel E, Spratt, Benjamin A, Teply, Jonathan, Tward, Dorothy A, Shead, Deborah A, Freedman-Cass
Publikováno v:
Journal of the National Comprehensive Cancer Network : JNCCN. 19(2)
The NCCN Guidelines for Prostate Cancer address staging and risk assessment after a prostate cancer diagnosis and include management options for localized, regional, and metastatic disease. Recommendations for disease monitoring and treatment of recu
Autor:
Anurag Saraf, Zhongyi Zhang, Jack Qian, Christian V Gurthier, Jakob Weiss, Vinayak Muralidhar, Subha Perni, Danielle Sara Bitterman, Benjamin Harris Kann, Anthony Victor D'Amico, Hugo Aerts, Raymond H. Mak, Paul L. Nguyen
Publikováno v:
Journal of Clinical Oncology. 40:159-159
159 Background: Androgen deprivation therapy (ADT) is a standard of care for high-risk prostate cancer, but treatment tolerance is variable. Prior work has demonstrated the correlation between body composition (BC) and clinical outcomes in prostate c
Autor:
Anthony Victor D'Amico, Wanling Xie, Elizabeth McMahon, Marian Loffredo, Shana Medeiros, David John Joseph, James William Denham, David S Lamb, Parvesh Kumar, Glenn Bubley, Molly A. Sullivan, Richard Hellwig, Juan Carlos Vera, Rolf Freter, W. Jeffrey Baker, Jeffrey Y.C. Wong, Andrew A. Renshaw, Philip W. Kantoff
Publikováno v:
Journal of Clinical Oncology. 39:5011-5011
5011 Background: For men with unfavorable-risk non-metastatic (M0) prostate cancer (PC) the addition of docetaxel to radical prostatectomy (RP) or radiation therapy (RT) and androgen deprivation therapy (ADT) has been studied in 6 randomized controll
Autor:
Bryant Alex, Anthony Victor D'Amico, Paul Nguyen, John Paul Einck, Christopher J. Kane, Rana R. McKay, Daniel Robert Simpson, Arno James Mundt, James Don Murphy, Brent Shane Rose
Publikováno v:
Journal of Clinical Oncology. 36:99-99
99 Background: Prostate-specific antigen (PSA) measurement after definitive radiation therapy (RT) and androgen deprivation therapy (ADT) for localized prostate cancer (PC) has been proposed as an early prognostic biomarker. We investigate the associ
Autor:
Ayal Aizer, Jonathan J. Paly, Anthony L. Zietman, Anthony Victor D'Amico, Paul Linh Nguyen, Clair Beard, Sandhya K Rao, Irving D. Kaplan, Michelle S. Hirsch, Chin-Lee Wu, Jason Alexander Efstathiou
Publikováno v:
Journal of Clinical Oncology. 30:131-131
131 Background: Factors associated with pursuit of active surveillance in men with low-risk prostate cancer are not well-delineated. Methods: 701 patients with low-risk prostate cancer (clinical stage < T2b, Gleason score < 7, and PSA < 10 ng/mL), tr